Predictive Oncology Inc. (NASDAQ:POAI)‎: Market Capitalization Reached at $13.61Million‎


5 Stocks to make up the PERFECT 2021 gold portfolio

Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.

Click here to download your free report right away

Sponsored


Get the hottest stocks to trade every day before the market opens ‎‎100% free. Click here now.

Wall Street analysts tracking the Predictive Oncology Inc. (NASDAQ: POAI) stock on daily basis. Out of 0 ‎analysts, 0 deeming the stock a Buy and 0 gave it a rating of OVERWEIGHT. Another 0 recommended ‎that POAI is a HOLD, while 0 rated it UNDERWEIGHT and the same number recommended SELL.‎

‎ The company’s revenue for the quarter stood at $480.8 million.‎

The stock market has more often than not ended up being extremely baffling, catching even some of ‎the more experienced traders by surprise. It happens that even when results are as projected, the ‎market sometimes just takes a sudden turn towards the opposite direction. Often such events lead to ‎doubt and much speculation. At such time, it may pay to keep tabs on a stock’s historical price ‎performance. Useful also would be knowledge of the stock’s trends, both the short term and long-‎term. Predictive Oncology Inc. (NASDAQ: POAI) share prices have increased by 9.70% over the past ‎week, but are down -17.98% over prices posted in the last quarter. Going further back, the stock’s ‎price has gone over -58.66% over the last 6 months but is down -70.54% in year-to-date trading.‎

A recent spot check on the stock’s support and resistance revealed that the publicly-traded Predictive ‎Oncology Inc. (NASDAQ: POAI) shares are trading at a price close to -26.06% lower than its 90-day high. ‎On the other hand, the stock is +22.06% away from its low in the 90-day period. More broadly, POAI’s ‎current price is -85.49% away from 52-week high. The price is 22.06% above from its 52-week low.‎

For regular shareholders interested in finding out how worthwhile it would be to invest in the ‎company, then note that Predictive Oncology Inc. has an ROE of -252.30%. An analysis will help ‎understand that the lower the ROE figure; the worse a company is when it comes to generating ‎profits. The term Return on Assets (ROA) is a ratio that points to a businesses’ profitability relative to ‎overall assets. The company under our focus has a current ROA of -114.60%. If a business manages its ‎assets well, then the ROA will be higher. However, the opposite will be true (lower returns) if that ‎business is shown to be poor managers of their assets. A look at another ratio shows that Predictive ‎Oncology Inc. has a Return on Investment (ROI) of -145.20%. When profits exceed costs, then the ROI ‎percentage will be positive, and analysts will rate such business as having a net gain. However, if the ‎percentage index is negative, then the company’s costs basically outweigh profits.‎

Focusing on the company’s market volatility shows that it has a 1-Week Volatility index of 11.41%, and ‎‎9.58% for the month. This stock’s Average True Range (ATR) currently stands at 0.06, with the beta ‎factor poised at 1.66. The indicator of Volatility helps exhibit the extent to which a stock is likely to ‎plummet or climb when the rest of the market also dips or surges. If a stock has a beta score above 1, ‎then its rate of volatility is high. Figures lower than 1, therefore, means that the stock’s volatility at that ‎particular moment is low.‎

Get the hottest stocks to trade every day before the market opens ‎‎100% free. Click here now.

Shares of the Predictive Oncology Inc. (NASDAQ: POAI) ‎gained by $0.11 during Wednesday’s regular trading session to climb to $0.77. The company had a daily ‎trading volume of 11.43 million shares, higher than its average intra-day trading volumes of about ‎‎1.10M shares.


This Secret NYSE Telecom Trading at $1.36 gets $35.00 Price Target by 2 Analyst!

There ‎is a secret stock that is LOADED with opportunity for savvy investors to make a ‎fortune!

Get all the details here >>

Sponsored


Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Edward Bosworth
I am not the run of the mill investigator. I have interesting abilities, sharpened by long stretches of fruitful Mergers and Acquisition achievements, to discover thrashed stocks that have the potential for recuperation and development. These organizations are useful in adjusting a portfolio just as beating the market. This experience left with solid thankfulness for principal investigation of an organization’s organizations instead of the entire partnership, to discover what will drive the outcomes.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Private Investors Pumped GameStop (GME) Stock Up

Shares of GameStop Corp (GME) video games grew by 144.8 percent, to $159.18, backed by mid-session trade. In contrast, the company's shares were worth...

DDOG Stock: Datadog Inc (DDOG) Is Still Worth a Bite

Since the start of the year, Datadog Inc. (NASDAQ: DDOG) shares have soared by 150%. Many citations confirm the company's position as one of...

Related Articles

Private Investors Pumped GameStop (GME) Stock Up

Shares of GameStop Corp (GME) video games grew by 144.8 percent, to $159.18, backed by mid-session trade. In contrast, the company's shares were worth...

DDOG Stock: Datadog Inc (DDOG) Is Still Worth a Bite

Since the start of the year, Datadog Inc. (NASDAQ: DDOG) shares have soared by 150%. Many citations confirm the company's position as one of...

Here Is how 3D Hubs Acquisition Will Benefits Proto Labs (PRLB)

On January 20, Proto Labs Inc (NYSE: PRLB) stock rose 6.56% to reach a closing price of $191.46. This resulted from the announcement that...

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.